285 related articles for article (PubMed ID: 31506573)
1. A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice.
Yan XX; Li HL; Zhang YT; Wu SY; Lu HL; Yu XL; Meng FG; Sun JH; Gong LK
Acta Pharmacol Sin; 2020 Mar; 41(3):348-357. PubMed ID: 31506573
[TBL] [Abstract][Full Text] [Related]
2. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.
Ali J; Khan AU; Shah FA; Ali H; Islam SU; Kim YS; Khan S
Life Sci; 2019 Dec; 239():116888. PubMed ID: 31639401
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model.
Yoneda J; Nishikawa S; Kurihara S
BMC Cancer; 2021 Dec; 21(1):1343. PubMed ID: 34922485
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
[TBL] [Abstract][Full Text] [Related]
5. The Superoxide Dismutase Mimetic M40403, Improves 5-Fluorouracil-induced Small Intestinal Mucositis in a Mouse Model.
Yim SK; Kim KM; Lee CH; Song EK; Lee SO; Kim SW; Kim IH; Kim SH; Seo SY; Lee ST
In Vivo; 2021; 35(3):1485-1497. PubMed ID: 33910826
[TBL] [Abstract][Full Text] [Related]
6. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.
Yasuda M; Kato S; Yamanaka N; Iimori M; Matsumoto K; Utsumi D; Kitahara Y; Amagase K; Horie S; Takeuchi K
Br J Pharmacol; 2013 Mar; 168(6):1388-400. PubMed ID: 23072534
[TBL] [Abstract][Full Text] [Related]
7. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
[TBL] [Abstract][Full Text] [Related]
8. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents.
Atiq A; Shal B; Naveed M; Khan A; Ali J; Zeeshan S; Al-Sharari SD; Kim YS; Khan S
Eur J Pharmacol; 2019 Jan; 843():292-306. PubMed ID: 30529194
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
[TBL] [Abstract][Full Text] [Related]
10. Mucoprotective effect of ellagic acid in 5 fluorouracil-induced intestinal mucositis model.
Al-Hoshary DM; Zalzala MH
J Med Life; 2023 May; 16(5):712-718. PubMed ID: 37520490
[TBL] [Abstract][Full Text] [Related]
11. Puerarin Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting JAKs.
Wang L; Song B; Hu Y; Chen J; Zhang S; Chen D; Wang J
J Pharmacol Exp Ther; 2021 Nov; 379(2):147-155. PubMed ID: 34400527
[TBL] [Abstract][Full Text] [Related]
12. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
[TBL] [Abstract][Full Text] [Related]
13. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
[TBL] [Abstract][Full Text] [Related]
14. Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.
Li HL; Lu L; Wang XS; Qin LY; Wang P; Qiu SP; Wu H; Huang F; Zhang BB; Shi HL; Wu XJ
Front Cell Infect Microbiol; 2017; 7():455. PubMed ID: 29124041
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model.
Shen SR; Chen WJ; Chu HF; Wu SH; Wang YR; Shen TL
PLoS One; 2021; 16(7):e0253540. PubMed ID: 34310611
[TBL] [Abstract][Full Text] [Related]
16. Protective effect and potential mechanisms of Wei-Chang-An pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice.
Chen Y; Zheng H; Zhang J; Wang L; Jin Z; Gao W
J Ethnopharmacol; 2016 Aug; 190():200-11. PubMed ID: 27240747
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress.
Zeeshan M; Atiq A; Ain QU; Ali J; Khan S; Ali H
Inflammopharmacology; 2021 Oct; 29(5):1539-1553. PubMed ID: 34420176
[TBL] [Abstract][Full Text] [Related]
19. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
20. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
